← 產業報告目錄
Botulinum Toxin in Urology Market Size, Share & Trends Analysis Report By Application (Overactive Bladder, Neurogenic Detrusor Overactivity), By End-use (Hospitals, Urology Clinics), By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-13頁數 180報告編號 INSIGHTACE-98291aec57
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 948.56 Mn as of 2023, the global Botulinum Toxin in Urology Market is forecasted to climb to USD 1,504.89 Mn by 2031, reflecting a compound annual growth rate of 6.05% over the 2024–2031 period.
Botulinum Toxin in Urology encompasses challenges.
The market's upward path is propelled by expanding healthcare spending, technological evolution, and the expanding focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Botulinum Toxin In Urology Market Snapshot
Chapter 4. Global Botulinum Toxin In Urology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Application Estimates & Trend Analysis
5.1. By Application, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
5.2.1. Overactive Bladder
5.2.2. Neurogenic Detrusor Overactivity
Chapter 6. Market Segmentation 2: By End-User Estimates & Trend Analysis
6.1. By End-User & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-User:
6.2.1. Hospitals
6.2.2. Urology Clinics
Chapter 7. Botulinum Toxin In Urology Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Botulinum Toxin In Urology Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
7.1.2. North America Botulinum Toxin In Urology Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
7.1.3. North America Botulinum Toxin In Urology Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
7.2. Europe
7.2.1. Europe Botulinum Toxin In Urology Market revenue (US$ Million) By Application, 2024-2031
7.2.2. Europe Botulinum Toxin In Urology Market revenue (US$ Million) By End-User, 2024-2031
7.2.3. Europe Botulinum Toxin In Urology Market revenue (US$ Million) by country, 2024-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Botulinum Toxin In Urology Market revenue (US$ Million) By Application, 2024-2031
7.3.2. Asia Pacific Botulinum Toxin In Urology Market revenue (US$ Million) By End-User, 2024-2031
7.3.3. Asia Pacific Botulinum Toxin In Urology Market revenue (US$ Million) by country, 2024-2031
7.4. Latin America
7.4.1. Latin America Botulinum Toxin In Urology Market revenue (US$ Million) By Application, (US$ Million) 2024-2031
7.4.2. Latin America Botulinum Toxin In Urology Market revenue (US$ Million) By End-User, (US$ Million) 2024-2031
7.4.3. Latin America Botulinum Toxin In Urology Market revenue (US$ Million) by country, 2024-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Botulinum Toxin In Urology Market revenue (US$ Million) By Application, (US$ Million) 2024-2031
7.5.2. Middle East & Africa Botulinum Toxin In Urology Market revenue (US$ Million) By End-User, (US$ Million) 2024-2031
7.5.3. Middle East & Africa Botulinum Toxin In Urology Market revenue (US$ Million) by country, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. AbbVie Inc.
8.2.2. Merz Pharma
8.2.3. Ipsen Pharma
8.2.4. GALDERMA
8.2.5. Allergan PLC
8.2.6. Sun Pharmaceutical Industries Ltd.
8.2.7. Biovencer Healthcare Pvt Ltd
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們